Results 241 to 250 of about 42,534 (266)

Cervical cancer prevention and control in women living with human immunodeficiency virus

Ca-A Cancer Journal for Clinicians, 2021
Philip E Castle, Vikrant V Sahasrabuddhe
exaly  

HIV-1 integrase inhibitors

The Biomedical & Life Sciences Collection, 2011
openaire   +1 more source

Integrase inhibitors to treat HIV/Aids

Nature Reviews Drug Discovery, 2005
Yves Pommier, Allison A Johnson
exaly  

HIV‐1 Integrase

2011
openaire   +1 more source

Dolutegravir versus raltegravir in antiretroviral-experienced, integrase-inhibitor-naive adults with HIV: week 48 results from the randomised, double-blind, non-inferiority SAILING study

Lancet, The, 2013
Andrey Shuldyakov, Carlos Brites, Jaime F Andrade-Villanueva   +2 more
exaly  

Safety and efficacy of the HIV-1 integrase inhibitor raltegravir (MK-0518) in treatment-experienced patients with multidrug-resistant virus: a phase II randomised controlled trial

Lancet, The, 2007
Jose M Gatell, Adriano Lazzarin
exaly  

Nuclear landscape of HIV-1 infection and integration

Nature Reviews Microbiology, 2016
Marina Lusic, Robert F Siliciano
exaly  

The structural biology of HIV-1: mechanistic and therapeutic insights

Nature Reviews Microbiology, 2012
Alan N Engelman, Peter P Cherepanov
exaly  

HIV-1 Integrase Binds the Viral RNA Genome and Is Essential during Virion Morphogenesis

Cell, 2016
Sebla B Kutluay, Alison Slaughter, James R Fuchs   +2 more
exaly  

Dipyrimidine-based inhibitors of HIV-1 integrase

Expert Opinion on Investigational Drugs, 2003
openaire   +2 more sources